Bio-Reference Laboratories Inc (NASDAQ:BRLI)
During the Trading Day
| 30.75 |  -0.46 / -1.47% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 31.21 |  +0.46 / +1.50% |
Volume: 2.8K |
Latest BRLI News | Press Releases
| July Options Now Available For Bio-Reference Laboratories (BRLI) May 20 / TheStreet.com | Whatbs Going On At Bio-Reference Labs? May 15 / StockTwits |
Today’s Trading
| Previous close | 31.21 |
| Today’s open | 31.10 |
| Day’s range | 30.48 - 31.36 |
| Volume | 279,630 |
| Average volume (3 months) | 399,481 |
| Market cap | $865.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +17.05% |
| Earnings growth (this year) | +17.71% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +18.44% |
| P/E ratio | 19.8 |
| Price/Sales | 1.16 |
| Price/Book | 3.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EXELExelixis Inc | -0.03 | -0.63% |
| NXTMNxstage Medical Inc | +0.27 | +1.99% |
| AMRNAmarin Corporation P... | -0.14 | -2.02% |
| KERXKeryx Biopharmaceuti... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | June 6, 2013 |
| EPS forecast (this quarter) | $0.41 |
| Annual revenue (last year) | $661.7M |
| Annual profit (last year) | $42.2M |
| Net profit margin | 6.37% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer Marc D. Grodman, MD |
Chief Operating Officer, Director & Executive VP Howard Dubinett |
Corporate headquarters Elmwood Park, New Jersey |
Forecasts
